Sripongpun, P.; Pinpathomrat, N.; Sophonmanee, R.; Ongarj, J.; Seepathomnarong, P.; Seeyankem, B.; Chamroonkul, N.; Piratvisuth, T.; Kaewdech, A., on behalf of the Cirrhosis-COVID-19 Vaccine Study Group.
Heterologous COVID-19 Vaccination and Booster with mRNA Vaccine Provide Enhanced Immune Response in Patients with Cirrhosis: A Prospective Observational Study. Vaccines 2023, 11, 1455.
https://doi.org/10.3390/vaccines11091455
AMA Style
Sripongpun P, Pinpathomrat N, Sophonmanee R, Ongarj J, Seepathomnarong P, Seeyankem B, Chamroonkul N, Piratvisuth T, Kaewdech A on behalf of the Cirrhosis-COVID-19 Vaccine Study Group.
Heterologous COVID-19 Vaccination and Booster with mRNA Vaccine Provide Enhanced Immune Response in Patients with Cirrhosis: A Prospective Observational Study. Vaccines. 2023; 11(9):1455.
https://doi.org/10.3390/vaccines11091455
Chicago/Turabian Style
Sripongpun, Pimsiri, Nawamin Pinpathomrat, Ratchanon Sophonmanee, Jomkwan Ongarj, Purilap Seepathomnarong, Bunya Seeyankem, Naichaya Chamroonkul, Teerha Piratvisuth, and Apichat Kaewdech on behalf of the Cirrhosis-COVID-19 Vaccine Study Group.
2023. "Heterologous COVID-19 Vaccination and Booster with mRNA Vaccine Provide Enhanced Immune Response in Patients with Cirrhosis: A Prospective Observational Study" Vaccines 11, no. 9: 1455.
https://doi.org/10.3390/vaccines11091455
APA Style
Sripongpun, P., Pinpathomrat, N., Sophonmanee, R., Ongarj, J., Seepathomnarong, P., Seeyankem, B., Chamroonkul, N., Piratvisuth, T., & Kaewdech, A., on behalf of the Cirrhosis-COVID-19 Vaccine Study Group.
(2023). Heterologous COVID-19 Vaccination and Booster with mRNA Vaccine Provide Enhanced Immune Response in Patients with Cirrhosis: A Prospective Observational Study. Vaccines, 11(9), 1455.
https://doi.org/10.3390/vaccines11091455
